Pharmacogenomics is the relationship between a patient’s unique genetic makeup and their response to certain medications. Genetic mutations can cause either higher or lower rates of metabolism for known drugs. According to the FDA, each year, approximately 4.5 million Americans visit their doctors or the emergency room due to adverse drug reactions.
Oxy-Gen uses the latest in high throughput DNA sequencing technology to analyze patient samples in an expedient and precise approach. All genetic scientists at Oxy-Gen are highly trained, handle testing with the utmost care, and are always available for in-depth consultations. Oxy-Gen pharmacogenomics reports are easy to read and provide you with clinically significant data based on the most recent medical innovations.